SCHEMBL4679943

SCHEMBL4679943

CCN(CC1CCN(S(=O)(=O)N(C)C)CC1)C(C)Cc1cccc(C(F)(F)F)c1.O=C(O)C(O)(C(=O)c1ccccc1)C(O)(C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.44
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 2/20 0.39
UBE2M P61081 2/20 0.39
DCUN1D1 Q96GG9 2/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
USP2 O75604 2/20 0.38
CYP3A4 P08684 2/20 0.38
NR1I2 O75469 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682466 0.92 KMT2A (0.43) CYP2D6KMT2ALMNAUBE2MDCUN1D1
SCHEMBL4680282 0.91 CYP2D6 (0.44) CYP2D6KMT2AALDH1A1LMNAOPRM1
SCHEMBL4678950 0.88 SMYD3 (0.40) CYP2D6KMT2AUBE2MDCUN1D1USP2
SCHEMBL4679944 0.88 CYP2D6 (0.42) CYP2D6KMT2AALDH1A1LMNAUBE2M
SCHEMBL4682814 0.85 KMT2A (0.40) CYP2D6KMT2AALDH1A1LMNAUBE2M
SCHEMBL4680484 0.84 CYP2D6 (0.57) CYP2D6KMT2AALDH1A1CHRM3CHRM5
Water SCHEMBL4680290 0.83 CNR1 (0.42) CYP2D6KMT2AALDH1A1UBE2MDCUN1D1
Hydrochloric Acid SCHEMBL4680409 0.81 CYP2D6 (0.59) CYP2D6KMT2ALMNAUBE2MDCUN1D1
Hydrochloric Acid SCHEMBL4686153 0.81 CYP2D6 (0.59) CYP2D6KMT2ALMNAUBE2MDCUN1D1
Hydrochloric Acid SCHEMBL4686164 0.81 CYP2D6 (0.59) CYP2D6KMT2ALMNAUBE2MDCUN1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed